Acceptability of Drugs in the Treatment of Unresectable/Metastatic BRAF V600-Mutant Melanoma: A Systematic Review and Network Meta-Analysis

BACKGROUND: Although many novel regimens have entered the treatment paradigm for unresectable/metastatic BRAF V600-mutant melanoma, there is still a lack of head-to-head comparison in terms of security. We conducted a network meta-analysis to compare the risk of adverse events (AEs) across different...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Ling, Huang, Ping, Zheng, Xiaochun, Ye, Xiaolan, Zhao, Hongying, Wang, Jianwei, Shao, Yanfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068943/
https://www.ncbi.nlm.nih.gov/pubmed/35530323
http://dx.doi.org/10.3389/fonc.2022.865656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068943/
https://www.ncbi.nlm.nih.gov/pubmed/35530323
http://dx.doi.org/10.3389/fonc.2022.865656

Ejemplares similares